Alfred S L Cheng

Author PubWeight™ 27.87‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant. Cancer Res 2006 2.63
2 FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells. PLoS One 2013 1.65
3 Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2. J Gastroenterol Hepatol 2011 1.38
4 Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res 2009 1.37
5 NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. Carcinogenesis 2010 1.35
6 Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer. PLoS One 2012 1.26
7 Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer. Carcinogenesis 2008 1.15
8 Epigenetic silencing mediated through activated PI3K/AKT signaling in breast cancer. Cancer Res 2011 1.13
9 Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis. J Clin Invest 2011 1.11
10 An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules. BMC Syst Biol 2009 1.08
11 Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro. Hepatology 2010 1.05
12 Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancer. Cancer Res 2012 1.03
13 Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis. Gut 2006 1.03
14 Hydrogen sulfide lowers proliferation and induces protective autophagy in colon epithelial cells. PLoS One 2012 1.01
15 Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis. Crit Rev Oncol Hematol 2012 0.97
16 Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer. Cancer 2011 0.96
17 A mixture model-based discriminate analysis for identifying ordered transcription factor binding site pairs in gene promoters directly regulated by estrogen receptor-alpha. Bioinformatics 2006 0.94
18 Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice. Biochem Biophys Res Commun 2008 0.92
19 Transgenic cyclooxygenase-2 expression and high salt enhanced susceptibility to chemical-induced gastric cancer development in mice. Carcinogenesis 2008 0.90
20 Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma. J Transl Med 2014 0.87
21 Targeted inhibition of COX-2 expression by RNA interference suppresses tumor growth and potentiates chemosensitivity to cisplatin in human gastric cancer cells. Oncol Rep 2007 0.86
22 Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma. Acta Neuropathol 2012 0.83
23 CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth. Cancer 2012 0.82
24 CUL4B: a novel epigenetic driver in Wnt/β-catenin-dependent hepatocarcinogenesis. J Pathol 2015 0.81
25 Correction: FK-16 Derived from the Anticancer Peptide LL-37 Induces Caspase-Independent Apoptosis and Autophagic Cell Death in Colon Cancer Cells. PLoS One 2015 0.77